HIV-1 vaccines and co-infection

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.4, Iss.9, 2004-09, pp. : 1483-1492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic and prophylactic DNA vaccines for HIV-1

By Ramirez Lorenzo Antonio Arango Tatiana Boyer Jean

Expert Opinion on Biological Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 563-573

Informa Healthcare

Access to resources Recommend Favorite

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines

By Hanke Tomáš

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 601-616

Informa Healthcare

Access to resources Recommend Favorite

Sphingolipids: Modulators of HIV-1 Infection and Pathogenesis

By Rawat Satinder

Bioscience Reports, Vol. 25, Iss. 5-6, 2005-10 ,pp. : 329-343

Springer Publishing Company

Access to resources Recommend Favorite

Expression and Coupling of Human Cytochrome P450 2E1 and NADPH-Cytochrome P450 Oxidoreductase in Dual Expression and Co-infection Systems with Baculovirus in Insect Cells

By Wang M.H. Patten C.J. Yang G.Y. Paranawithana S.R. Tan Y. Yang C.S.

Archives of Biochemistry and Biophysics, Vol. 334, Iss. 2, 1996-10 ,pp. : 380-388

Elsevier

Access to resources Recommend Favorite

Chimeric Synthetic Peptide as Antigen for Immunodiagnosis of HIV-1 Infection

By Hernández M. Pozo L. Gómez I. Melchor A.

Biochemical and Biophysical Research Communications, Vol. 272, Iss. 1, 2000-05 ,pp. : 259-262

Elsevier

Access to resources Recommend Favorite